Drug Development, Not Conflicts, Dominates Gottlieb's Confirmation Hearing
The most questions were asked about issues such as accelerated approval and clinical trials, not Gottlieb's ties to industry.
The most questions were asked about issues such as accelerated approval and clinical trials, not Gottlieb's ties to industry.